Morocco vs Switzerland: Cause of death, by non-communicable diseases, ages 60+, female
Morocco
83.7%
in 2021
Switzerland
83.9%
in 2021
Morocco rank
35th
Switzerland rank
34th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Morocco
- Switzerland
How they compare
Switzerland currently reports 83.9% against 83.7% in Morocco, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Morocco ahead.
Morocco ranks 35th and Switzerland ranks 34th of 185 countries.
Morocco has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Morocco | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.0% | 90.9% | 3.1% | Morocco |
| 2010s | 94.7% | 91.6% | 3.1% | Morocco |
| 2020s | 84.0% | 81.9% | 2.0% | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Morocco or Switzerland?
- Switzerland, at 83.9% against 83.7% in Morocco as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Morocco and Switzerland?
- 0.2%, with Switzerland ahead.
- How many years of comparable data are there for Morocco and Switzerland?
- 6 years are reported by both, from 2000 to 2021.
- How do Morocco and Switzerland rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Morocco ranks 35th and Switzerland ranks 34th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.